Thus, conceivably, additional bone-protective interventions may be necessary for obese patients carrying MC4R variants
In the context of Zepbound, "microdosing" refers to the practice of using doses lower than the FDA-approved starting dose of 2.5 mg weekly
However, many patients with NAFLD have comorbid conditions for which these medications are appropriately indicated, potentially providing dual metabolic and hepatic benefits
Readers who want to go deeper into the building blocks should draw on the linked individual monographs and the comparison with other substance classes to place the overall picture of growth hormone secretagogues
Thank you to Jabe and the MFM team. Espen Wold-Jensen CEO, Researcher and Founder, The Quantum Academy MFM provide a personalised approach to your health, energy and performance
Find out what studies have shown in our article about potential health benefits and risks of drinking coffee